Provided by Tiger Trade Technology Pte. Ltd.

InfuSystems

7.72
+0.15001.98%
Post-market: 7.720.00000.00%16:10 EST
Volume:137.14K
Turnover:1.05M
Market Cap:157.00M
PE:29.76
High:7.77
Open:7.54
Low:7.51
Close:7.57
52wk High:11.04
52wk Low:4.61
Shares:20.34M
Float Shares:18.07M
Volume Ratio:0.73
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.2594
EPS(LYR):0.1102
ROE:9.95%
ROA:7.24%
PB:2.83
PE(LYR):70.03

Loading ...

InfuSystem Holdings:Ambulatory Infusion Pumps Used in Pain Management Business by Co to Receive Separate Payment Under Nopain Act Starting Jan 1, 2026

THOMSON REUTERS
·
Dec 11, 2025

CMS Approves Separate Medicare Payment for InfuSystem Infusion Pumps Under NOPAIN Act

Reuters
·
Dec 11, 2025

InfuSystem Holdings Inc. to Participate at Craig-Hallum Alpha Select Conference

Reuters
·
Nov 11, 2025

InfuSystem Price Target Raised to $14.00/Share From $13.00 by Roth Capital

Dow Jones
·
Nov 06, 2025

InfuSystem Holdings (INFU): Net Margin Improves to 3.9%, Reinforcing Profitability Narrative

Simply Wall St.
·
Nov 05, 2025

InfuSystem price target raised to $14 from $13 at Roth Capital

TIPRANKS
·
Nov 05, 2025

Lake Street Sticks to Their Buy Rating for InfuSystem Holdings (INFU)

TIPRANKS
·
Nov 04, 2025

InfuSystem Q3 Gross Profit USD 20.82 Million

THOMSON REUTERS
·
Nov 04, 2025

InfuSystem Holdings Inc - Reaffirms Full-Year 2025 Guidance

THOMSON REUTERS
·
Nov 04, 2025

InfuSystem Q3 Revenue USD 36.488 Million

THOMSON REUTERS
·
Nov 04, 2025

InfuSystem Outlook FY Revenue Growth 6-8%

THOMSON REUTERS
·
Nov 04, 2025

InfuSystem Holdings reports Q3 net revenues of $36.5 million and net income of $2.3 million

Reuters
·
Nov 04, 2025

Press Release: InfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025

Dow Jones
·
Oct 29, 2025

InfuSystem Holdings Inc. to Release Third Quarter 2025 Results

Reuters
·
Oct 29, 2025

InfuSystem Holdings Inc. to Participate in 4th Annual ROTH Healthcare Opportunities Conference

Reuters
·
Sep 26, 2025

InfuSystem Coverage Assumed by Lake Street at Buy

Dow Jones
·
Sep 22, 2025

Director Scott Shuda Reports Disposal of Common Shares in InfuSystem Holdings Inc

Reuters
·
Aug 23, 2025

InfuSystem Updates Its Annual Guidance For The Full Year 2025 With Net Revenue Growth Estimated Of 6%-8%, Versus Prior Range Of 8%-10%

Benzinga
·
Aug 05, 2025

InfuSystems Holdings Q2 2025 EPS $0.12 Beats $0.04 Estimate, Sales $36.002M Miss $36.040M Estimate

Benzinga
·
Aug 05, 2025

InfuSystem Q2 2025: Net Revenues Up 7% to $36M, Net Income Surges 262% to $2.6M, EPS at $0.12

Reuters
·
Aug 05, 2025